| Alyse Culpepper, MA | |
|
1025 E Radiant Ridge Dr, Meridian, ID 83642-4013 | |
| (208) 994-4620 | |
| Not Available |
| Full Name | Alyse Culpepper |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 1025 E Radiant Ridge Dr, Meridian, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982314902 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | 133747 (California) | Secondary |
| 106H00000X | Marriage & Family Therapist | 9187 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Alyse Culpepper, MA 1025 E Radiant Ridge Dr, Meridian, ID 83642-4013 Ph: () - | Alyse Culpepper, MA 1025 E Radiant Ridge Dr, Meridian, ID 83642-4013 Ph: (208) 994-4620 |
News Archive
Rockefeller University scientists have discovered that the same enzyme that enables the immune system's defensive creativity is also responsible for a particular genetic malfunction - a translocation of one piece of DNA to the wrong chromosome - that causes Burkitt's lymphoma.
US-based pharmaceutical company Radient Pharmaceuticals Corporation (NYSE Amex: RPC) announced today the following update to its press release dated Monday, November 30, 2009 and entitled "Radient Pharma Completes Registered Direct Offering For Approximately $1 Million."
Kaposi sarcoma is unique among cancers because most tumors grow from a small number of different cells, whereas nearly all other cancers arise from a single cell, according to a study published online July 10 in the Journal of the National Cancer Institute.
ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced today that it has been featured in an in-depth report by Griffin Securities, a New York-based brokerage firm, highlighting the importance of the role that cancer stem cell (CSCs) targeting technology such as that employed by its lead product candidate, ICT-121, may play in developing future cancer treatments.
Amplification of the fibroblast growth factor receptor 1 gene independently predicts poor outcomes in patients who have undergone resection of squamous cell lung cancer, research shows.
› Verified 7 days ago
Joseph John Andersen, M.S. LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 667 E Grouse Ct, Meridian, ID 83646 Phone: 208-283-9888 | |
Mrs. Kendra Woolstenhulme, LCMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 3401 Nw 12th Ave, Meridian, ID 83646 Phone: 202-681-2277 | |
Joseph Smart, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 3288 E Pine Ave, Meridian, ID 83642 Phone: 208-871-5649 Fax: 208-658-0153 | |
Brionne Porter Chamberlain, MFT INTERN Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 750 W Ustick Rd Ste 120, Meridian, ID 83646 Phone: 208-600-2072 | |
Jeanne Anderson, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 565 E Woodbury Dr, Meridian, ID 83646 Phone: 208-724-8760 | |
Molly Nordstrom Hill, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 1548 W Cayuse Creek Dr Ste 100, Meridian, ID 83646 Phone: 208-600-2072 | |
Mrs. Stacy Pineda, LAMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 750 W Ustick Rd Ste 120, Meridian, ID 83646 Phone: 208-366-1678 |